nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0377	0.0503	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0377	0.0503	CbGbCtD
Lercanidipine—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0325	0.0435	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0325	0.0435	CbGbCtD
Lercanidipine—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0316	0.0422	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0316	0.0422	CbGbCtD
Lercanidipine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0312	0.0418	CbGbCtD
Lercanidipine—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0285	0.0382	CbGbCtD
Lercanidipine—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0285	0.0382	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0285	0.0382	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0285	0.0382	CbGbCtD
Lercanidipine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0283	0.0378	CbGbCtD
Lercanidipine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0283	0.0378	CbGbCtD
Lercanidipine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0244	0.0326	CbGbCtD
Lercanidipine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0237	0.0316	CbGbCtD
Lercanidipine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0214	0.0286	CbGbCtD
Lercanidipine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0214	0.0286	CbGbCtD
Lercanidipine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0204	0.0272	CbGbCtD
Lercanidipine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0192	0.0256	CbGbCtD
Lercanidipine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0192	0.0256	CbGbCtD
Lercanidipine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0173	0.0232	CbGbCtD
Lercanidipine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0173	0.0232	CbGbCtD
Lercanidipine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.015	0.02	CbGbCtD
Lercanidipine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0145	0.0194	CbGbCtD
Lercanidipine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0131	0.0175	CbGbCtD
Lercanidipine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0131	0.0175	CbGbCtD
Lercanidipine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.013	0.0173	CbGbCtD
Lercanidipine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0122	0.0163	CbGbCtD
Lercanidipine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0122	0.0163	CbGbCtD
Lercanidipine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.011	0.0147	CbGbCtD
Lercanidipine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.011	0.0147	CbGbCtD
Lercanidipine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00951	0.0127	CbGbCtD
Lercanidipine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00923	0.0123	CbGbCtD
Lercanidipine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00835	0.0112	CbGbCtD
Lercanidipine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00835	0.0112	CbGbCtD
Lercanidipine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00801	0.0107	CbGbCtD
Lercanidipine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000176	0.0755	CbGeAlD
Lercanidipine—CACNA1C—digestive system—acquired immunodeficiency syndrome	0.000138	0.059	CbGeAlD
Lercanidipine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000134	0.000539	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.000539	CcSEcCtD
Lercanidipine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000538	CcSEcCtD
Lercanidipine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000134	0.000538	CcSEcCtD
Lercanidipine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000134	0.000537	CcSEcCtD
Lercanidipine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000134	0.000536	CcSEcCtD
Lercanidipine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000536	CcSEcCtD
Lercanidipine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000535	CcSEcCtD
Lercanidipine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000535	CcSEcCtD
Lercanidipine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000534	CcSEcCtD
Lercanidipine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000534	CcSEcCtD
Lercanidipine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000534	CcSEcCtD
Lercanidipine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000133	0.000533	CcSEcCtD
Lercanidipine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000533	CcSEcCtD
Lercanidipine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000532	CcSEcCtD
Lercanidipine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000531	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000531	CcSEcCtD
Lercanidipine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000132	0.0566	CbGeAlD
Lercanidipine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000529	CcSEcCtD
Lercanidipine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000132	0.000528	CcSEcCtD
Lercanidipine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000528	CcSEcCtD
Lercanidipine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000528	CcSEcCtD
Lercanidipine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000528	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000527	CcSEcCtD
Lercanidipine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000527	CcSEcCtD
Lercanidipine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000526	CcSEcCtD
Lercanidipine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000131	0.000524	CcSEcCtD
Lercanidipine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000523	CcSEcCtD
Lercanidipine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00013	0.000523	CcSEcCtD
Lercanidipine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000522	CcSEcCtD
Lercanidipine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00013	0.0557	CbGeAlD
Lercanidipine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00013	0.000521	CcSEcCtD
Lercanidipine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00013	0.000521	CcSEcCtD
Lercanidipine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00013	0.00052	CcSEcCtD
Lercanidipine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.00052	CcSEcCtD
Lercanidipine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.00052	CcSEcCtD
Lercanidipine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000129	0.000519	CcSEcCtD
Lercanidipine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000129	0.000519	CcSEcCtD
Lercanidipine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000518	CcSEcCtD
Lercanidipine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000517	CcSEcCtD
Lercanidipine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000517	CcSEcCtD
Lercanidipine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000516	CcSEcCtD
Lercanidipine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000516	CcSEcCtD
Lercanidipine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000515	CcSEcCtD
Lercanidipine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000514	CcSEcCtD
Lercanidipine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000514	CcSEcCtD
Lercanidipine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000514	CcSEcCtD
Lercanidipine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000512	CcSEcCtD
Lercanidipine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000127	0.000511	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000511	CcSEcCtD
Lercanidipine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000509	CcSEcCtD
Lercanidipine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000508	CcSEcCtD
Lercanidipine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000506	CcSEcCtD
Lercanidipine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000505	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000505	CcSEcCtD
Lercanidipine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000504	CcSEcCtD
Lercanidipine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000503	CcSEcCtD
Lercanidipine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000503	CcSEcCtD
Lercanidipine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000503	CcSEcCtD
Lercanidipine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000125	0.000503	CcSEcCtD
Lercanidipine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000502	CcSEcCtD
Lercanidipine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000501	CcSEcCtD
Lercanidipine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000125	0.000501	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000501	CcSEcCtD
Lercanidipine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000501	CcSEcCtD
Lercanidipine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.0005	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.0005	CcSEcCtD
Lercanidipine—CACNA1D—lung—acquired immunodeficiency syndrome	0.000125	0.0534	CbGeAlD
Lercanidipine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000124	0.000499	CcSEcCtD
Lercanidipine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000499	CcSEcCtD
Lercanidipine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000497	CcSEcCtD
Lercanidipine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000497	CcSEcCtD
Lercanidipine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000497	CcSEcCtD
Lercanidipine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000495	CcSEcCtD
Lercanidipine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000495	CcSEcCtD
Lercanidipine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000123	0.000495	CcSEcCtD
Lercanidipine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000123	0.000494	CcSEcCtD
Lercanidipine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000494	CcSEcCtD
Lercanidipine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000123	0.000494	CcSEcCtD
Lercanidipine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000492	CcSEcCtD
Lercanidipine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000123	0.000492	CcSEcCtD
Lercanidipine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000491	CcSEcCtD
Lercanidipine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000491	CcSEcCtD
Lercanidipine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000491	CcSEcCtD
Lercanidipine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000489	CcSEcCtD
Lercanidipine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000488	CcSEcCtD
Lercanidipine—CACNA1C—vagina—acquired immunodeficiency syndrome	0.000122	0.0521	CbGeAlD
Lercanidipine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000487	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000487	CcSEcCtD
Lercanidipine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000487	CcSEcCtD
Lercanidipine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000485	CcSEcCtD
Lercanidipine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000485	CcSEcCtD
Lercanidipine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000484	CcSEcCtD
Lercanidipine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000484	CcSEcCtD
Lercanidipine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000483	CcSEcCtD
Lercanidipine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000121	0.000483	CcSEcCtD
Lercanidipine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000483	CcSEcCtD
Lercanidipine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00012	0.000482	CcSEcCtD
Lercanidipine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000481	CcSEcCtD
Lercanidipine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.00048	CcSEcCtD
Lercanidipine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000119	0.000479	CcSEcCtD
Lercanidipine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000119	0.000479	CcSEcCtD
Lercanidipine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000479	CcSEcCtD
Lercanidipine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000479	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000478	CcSEcCtD
Lercanidipine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000119	0.000478	CcSEcCtD
Lercanidipine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000477	CcSEcCtD
Lercanidipine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000119	0.000477	CcSEcCtD
Lercanidipine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000477	CcSEcCtD
Lercanidipine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000477	CcSEcCtD
Lercanidipine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000119	0.000476	CcSEcCtD
Lercanidipine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000118	0.000475	CcSEcCtD
Lercanidipine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000118	0.000475	CcSEcCtD
Lercanidipine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000474	CcSEcCtD
Lercanidipine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000474	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000473	CcSEcCtD
Lercanidipine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000473	CcSEcCtD
Lercanidipine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000117	0.000471	CcSEcCtD
Lercanidipine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000117	0.00047	CcSEcCtD
Lercanidipine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.00047	CcSEcCtD
Lercanidipine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000117	0.000468	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000467	CcSEcCtD
Lercanidipine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000116	0.000466	CcSEcCtD
Lercanidipine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000466	CcSEcCtD
Lercanidipine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000463	CcSEcCtD
Lercanidipine—CACNA1D—nervous system—acquired immunodeficiency syndrome	0.000115	0.0494	CbGeAlD
Lercanidipine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000463	CcSEcCtD
Lercanidipine—CACNA1C—lung—acquired immunodeficiency syndrome	0.000115	0.0493	CbGeAlD
Lercanidipine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000461	CcSEcCtD
Lercanidipine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000461	CcSEcCtD
Lercanidipine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.00046	CcSEcCtD
Lercanidipine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.00046	CcSEcCtD
Lercanidipine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.00046	CcSEcCtD
Lercanidipine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000458	CcSEcCtD
Lercanidipine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000458	CcSEcCtD
Lercanidipine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000457	CcSEcCtD
Lercanidipine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000457	CcSEcCtD
Lercanidipine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000456	CcSEcCtD
Lercanidipine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000455	CcSEcCtD
Lercanidipine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000455	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000453	CcSEcCtD
Lercanidipine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000113	0.000452	CcSEcCtD
Lercanidipine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000451	CcSEcCtD
Lercanidipine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000451	CcSEcCtD
Lercanidipine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000451	CcSEcCtD
Lercanidipine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000112	0.00045	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000449	CcSEcCtD
Lercanidipine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000448	CcSEcCtD
Lercanidipine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000446	CcSEcCtD
Lercanidipine—CACNA1D—central nervous system—acquired immunodeficiency syndrome	0.000111	0.0476	CbGeAlD
Lercanidipine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000445	CcSEcCtD
Lercanidipine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000111	0.000443	CcSEcCtD
Lercanidipine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000443	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000442	CcSEcCtD
Lercanidipine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000442	CcSEcCtD
Lercanidipine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.00044	CcSEcCtD
Lercanidipine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00011	0.00044	CcSEcCtD
Lercanidipine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000439	CcSEcCtD
Lercanidipine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000439	CcSEcCtD
Lercanidipine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000438	CcSEcCtD
Lercanidipine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000438	CcSEcCtD
Lercanidipine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000438	CcSEcCtD
Lercanidipine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000438	CcSEcCtD
Lercanidipine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000436	CcSEcCtD
Lercanidipine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000434	CcSEcCtD
Lercanidipine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000433	CcSEcCtD
Lercanidipine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000428	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000428	CcSEcCtD
Lercanidipine—CACNA1C—nervous system—acquired immunodeficiency syndrome	0.000106	0.0456	CbGeAlD
Lercanidipine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000426	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000426	CcSEcCtD
Lercanidipine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000425	CcSEcCtD
Lercanidipine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000425	CcSEcCtD
Lercanidipine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000422	CcSEcCtD
Lercanidipine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000422	CcSEcCtD
Lercanidipine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000422	CcSEcCtD
Lercanidipine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000419	CcSEcCtD
Lercanidipine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000419	CcSEcCtD
Lercanidipine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.000419	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000419	CcSEcCtD
Lercanidipine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000418	CcSEcCtD
Lercanidipine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.000415	CcSEcCtD
Lercanidipine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000415	CcSEcCtD
Lercanidipine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000415	CcSEcCtD
Lercanidipine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000414	CcSEcCtD
Lercanidipine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000413	CcSEcCtD
Lercanidipine—CACNA1C—central nervous system—acquired immunodeficiency syndrome	0.000103	0.0439	CbGeAlD
Lercanidipine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000409	CcSEcCtD
Lercanidipine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000409	CcSEcCtD
Lercanidipine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000408	CcSEcCtD
Lercanidipine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000407	CcSEcCtD
Lercanidipine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000406	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000406	CcSEcCtD
Lercanidipine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000405	CcSEcCtD
Lercanidipine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000405	CcSEcCtD
Lercanidipine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000405	CcSEcCtD
Lercanidipine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000405	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000403	CcSEcCtD
Lercanidipine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000402	CcSEcCtD
Lercanidipine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	9.91e-05	0.000397	CcSEcCtD
Lercanidipine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	9.87e-05	0.000396	CcSEcCtD
Lercanidipine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	9.77e-05	0.000392	CcSEcCtD
Lercanidipine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	9.76e-05	0.000392	CcSEcCtD
Lercanidipine—Nausea—Zidovudine—acquired immunodeficiency syndrome	9.75e-05	0.000391	CcSEcCtD
Lercanidipine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	9.71e-05	0.00039	CcSEcCtD
Lercanidipine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	9.71e-05	0.00039	CcSEcCtD
Lercanidipine—Vomiting—Indinavir—acquired immunodeficiency syndrome	9.71e-05	0.000389	CcSEcCtD
Lercanidipine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	9.66e-05	0.000387	CcSEcCtD
Lercanidipine—Rash—Indinavir—acquired immunodeficiency syndrome	9.63e-05	0.000386	CcSEcCtD
Lercanidipine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	9.62e-05	0.000386	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	9.59e-05	0.000385	CcSEcCtD
Lercanidipine—Headache—Indinavir—acquired immunodeficiency syndrome	9.57e-05	0.000384	CcSEcCtD
Lercanidipine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	9.54e-05	0.000383	CcSEcCtD
Lercanidipine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	9.45e-05	0.000379	CcSEcCtD
Lercanidipine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	9.41e-05	0.000377	CcSEcCtD
Lercanidipine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	9.31e-05	0.000374	CcSEcCtD
Lercanidipine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.27e-05	0.000372	CcSEcCtD
Lercanidipine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.27e-05	0.000372	CcSEcCtD
Lercanidipine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	9.17e-05	0.000368	CcSEcCtD
Lercanidipine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	9.16e-05	0.000367	CcSEcCtD
Lercanidipine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	9.13e-05	0.000366	CcSEcCtD
Lercanidipine—Rash—Efavirenz—acquired immunodeficiency syndrome	9.1e-05	0.000365	CcSEcCtD
Lercanidipine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	9.09e-05	0.000365	CcSEcCtD
Lercanidipine—Nausea—Indinavir—acquired immunodeficiency syndrome	9.07e-05	0.000364	CcSEcCtD
Lercanidipine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	9.05e-05	0.000363	CcSEcCtD
Lercanidipine—Headache—Efavirenz—acquired immunodeficiency syndrome	9.04e-05	0.000363	CcSEcCtD
Lercanidipine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	9.03e-05	0.000362	CcSEcCtD
Lercanidipine—CACNA1D—brain—acquired immunodeficiency syndrome	8.82e-05	0.0378	CbGeAlD
Lercanidipine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8.82e-05	0.000354	CcSEcCtD
Lercanidipine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	8.78e-05	0.000352	CcSEcCtD
Lercanidipine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8.74e-05	0.00035	CcSEcCtD
Lercanidipine—Rash—Delavirdine—acquired immunodeficiency syndrome	8.71e-05	0.000349	CcSEcCtD
Lercanidipine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8.7e-05	0.000349	CcSEcCtD
Lercanidipine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8.69e-05	0.000349	CcSEcCtD
Lercanidipine—Headache—Delavirdine—acquired immunodeficiency syndrome	8.65e-05	0.000347	CcSEcCtD
Lercanidipine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	8.64e-05	0.000346	CcSEcCtD
Lercanidipine—Nausea—Efavirenz—acquired immunodeficiency syndrome	8.57e-05	0.000344	CcSEcCtD
Lercanidipine—CACNA1D—lymph node—acquired immunodeficiency syndrome	8.52e-05	0.0365	CbGeAlD
Lercanidipine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.44e-05	0.000339	CcSEcCtD
Lercanidipine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.41e-05	0.000337	CcSEcCtD
Lercanidipine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.41e-05	0.000337	CcSEcCtD
Lercanidipine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.29e-05	0.000333	CcSEcCtD
Lercanidipine—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.2e-05	0.000329	CcSEcCtD
Lercanidipine—CACNA1C—brain—acquired immunodeficiency syndrome	8.14e-05	0.0349	CbGeAlD
Lercanidipine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	8.13e-05	0.000326	CcSEcCtD
Lercanidipine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	8.12e-05	0.000326	CcSEcCtD
Lercanidipine—Rash—Ritonavir—acquired immunodeficiency syndrome	8.05e-05	0.000323	CcSEcCtD
Lercanidipine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	8.04e-05	0.000323	CcSEcCtD
Lercanidipine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	8.02e-05	0.000322	CcSEcCtD
Lercanidipine—Headache—Ritonavir—acquired immunodeficiency syndrome	8e-05	0.000321	CcSEcCtD
Lercanidipine—CACNA1C—lymph node—acquired immunodeficiency syndrome	7.86e-05	0.0337	CbGeAlD
Lercanidipine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.81e-05	0.000313	CcSEcCtD
Lercanidipine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.75e-05	0.000311	CcSEcCtD
Lercanidipine—Rash—Saquinavir—acquired immunodeficiency syndrome	7.75e-05	0.000311	CcSEcCtD
Lercanidipine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.74e-05	0.00031	CcSEcCtD
Lercanidipine—Headache—Saquinavir—acquired immunodeficiency syndrome	7.7e-05	0.000309	CcSEcCtD
Lercanidipine—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.58e-05	0.000304	CcSEcCtD
Lercanidipine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.45e-05	0.000299	CcSEcCtD
Lercanidipine—Rash—Lamivudine—acquired immunodeficiency syndrome	7.39e-05	0.000296	CcSEcCtD
Lercanidipine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.38e-05	0.000296	CcSEcCtD
Lercanidipine—Headache—Lamivudine—acquired immunodeficiency syndrome	7.34e-05	0.000295	CcSEcCtD
Lercanidipine—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.3e-05	0.000293	CcSEcCtD
Lercanidipine—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.96e-05	0.000279	CcSEcCtD
Lercanidipine—CYP3A5—digestive system—acquired immunodeficiency syndrome	6.77e-05	0.029	CbGeAlD
Lercanidipine—CYP3A5—blood—acquired immunodeficiency syndrome	6.45e-05	0.0276	CbGeAlD
Lercanidipine—CYP3A5—vagina—acquired immunodeficiency syndrome	5.98e-05	0.0256	CbGeAlD
Lercanidipine—CYP3A5—lung—acquired immunodeficiency syndrome	5.66e-05	0.0242	CbGeAlD
Lercanidipine—CYP3A4—digestive system—acquired immunodeficiency syndrome	5.08e-05	0.0218	CbGeAlD
Lercanidipine—CYP2D6—digestive system—acquired immunodeficiency syndrome	5e-05	0.0214	CbGeAlD
Lercanidipine—CYP3A4—blood—acquired immunodeficiency syndrome	4.84e-05	0.0207	CbGeAlD
Lercanidipine—CYP2D6—blood—acquired immunodeficiency syndrome	4.77e-05	0.0204	CbGeAlD
Lercanidipine—CYP3A4—nervous system—acquired immunodeficiency syndrome	3.93e-05	0.0168	CbGeAlD
Lercanidipine—CYP2D6—nervous system—acquired immunodeficiency syndrome	3.87e-05	0.0166	CbGeAlD
Lercanidipine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	3.79e-05	0.0162	CbGeAlD
Lercanidipine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	3.73e-05	0.016	CbGeAlD
Lercanidipine—CYP2D6—brain—acquired immunodeficiency syndrome	2.96e-05	0.0127	CbGeAlD
